Insulin resistance and insulin sensitizers.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 11684868)

Published in Horm Res on January 01, 2001

Authors

M Stumvoll1, H Häring

Author Affiliations

1: Medizinische Klinik, Abteilung für Endokrinologie, Stoffwechsel und Pathobiochemie, Eberhard-Karls-Universität, Tübingen, Germany.

Articles by these authors

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16

The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53

Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Diabetologia (2000) 1.19

Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. J Biol Chem (1986) 1.15

Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest (1996) 1.14

Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res (2005) 1.07

Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes (2001) 1.05

At last, a weight neutral insulin? Int J Obes Relat Metab Disord (2004) 1.03

Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochem J (1986) 1.03

Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes (2001) 1.02

A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest (2000) 1.01

Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Horm Metab Res (2001) 0.95

Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene. Diabetes (2001) 0.93

The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes (2001) 0.92

Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab (2000) 0.91

Reduced lipolysis as possible cause for greater weight gain in subjects with the Pro12Ala polymorphism in PPARgamma2? Diabetologia (2002) 0.91

Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem (1994) 0.90

An Mr 180,000 protein is an endogenous substrate for the insulin-receptor-associated tyrosine kinase in human placenta. Biochem J (1987) 0.89

Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta. Eur J Biochem (1994) 0.89

Phosphorylation of two cytosolic proteins. An early event of T-cell activation. Biochem J (1989) 0.88

Multiple sites of insulin resistance: muscle, liver and adipose tissue. Exp Clin Endocrinol Diabetes (1999) 0.87

The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Exp Clin Endocrinol Diabetes (2004) 0.87

Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes (1994) 0.84

Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med (2001) 0.84

Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. J Clin Endocrinol Metab (2001) 0.84

Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10. Diabetologia (2002) 0.83

Acute stimulation of leptin concentrations in humans during hyperglycemic hyperinsulinemia. Influence of free fatty acids and fasting. Int J Obes Relat Metab Disord (2001) 0.83

Evidence for inhibition of leptin secretion by catecholamines in man. Exp Clin Endocrinol Diabetes (1998) 0.82

[Polymorphism of pro12Ala in peroxisome proliferator activated receptor gamma 2 (PPAgamma2): beta cell function and insulin sensitivity]. Dtsch Med Wochenschr (2001) 0.80

Leptin levels in humans are acutely suppressed by isoproterenol despite acipimox-induced inhibition of lipolysis, but not by free fatty acids. Metabolism (2000) 0.80

The role of beta-adrenergic sensitivity in the pathogenesis of hypoglycaemia unawareness. Diabetes Nutr Metab (2002) 0.79

Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes. Diabetes Care (2000) 0.79

A novel use of the hyperinsulinemic-euglycemic clamp technique to estimate insulin sensitivity of systemic lipolysis. Horm Metab Res (2001) 0.78

The prevalent Gly1057Asp polymorphism in the insulin receptor substrate-2 gene is not associated with impaired insulin secretion. J Clin Endocrinol Metab (2001) 0.78

[White blood cell count as a predictor of glucose tolerance and insulin sensitivity. The role of inflammation in the pathogenesis of type 2 diabetes mellitus]. Dtsch Med Wochenschr (2004) 0.77

The OGTT as test for beta cell function? Eur J Clin Invest (2001) 0.77

Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects. Horm Metab Res (2001) 0.76

Bradykinin induces tyrosine phosphorylation in human foreskin fibroblasts and 293 cells transfected with rat B2 kinin receptor. Eur J Biochem (1996) 0.75

[Reduced insulin effect in subclinical fatty liver]. Dtsch Med Wochenschr (2004) 0.75

Retracted Two novel prevalent polymorphisms in the hormone-sensitive lipase gene have no effect on insulin sensitivity of lipolysis and glucose disposal. J Lipid Res (2001) 0.75

[Clinical-experimental study of muscle activity of complete denture wearers with various prostheses before and after equilibration]. ZWR (1991) 0.75

The Search for NIDDM genes project: a European Community programme aimed to facilitate the identification of NIDDM genes. Diabetologia (1998) 0.75

For debate: Starling's curve of the pancreas--overuse of a concept? Horm Metab Res (2003) 0.75

Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans. Diabetologia (2000) 0.75

Effects of repeated treatment with sodium 2,3-dimercaptopropane-1-sulfonate in beagle dogs. Arzneimittelforschung (1983) 0.75

Insulin binding and insulin action in rat fat cells after adrenalectomy. Diabetologia (1980) 0.75

A 60 minute hyperglycemic clamp is sufficient to assess both phases of insulin secretion. Horm Metab Res (2000) 0.75